Status:
COMPLETED
Identification of New Diagnostic Protein Markers for Colorectal Cancer
Lead Sponsor:
CHU de Reims
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The search for biochemical markers in patient's blood for non-invasive colorectal cancer diagnostic has not yielded satisfactory results to date. The search for blood in the stool by enzymatic techniq...
Detailed Description
In terms of frequency, colorectal cancer is the third most common cancer diagnosed in men and the second in women. Screening for colon and rectal cancer is based on the search for blood in the stool. ...
Eligibility Criteria
Inclusion
- Immunoassay for stool positive blood test or family screening
- Patients seen in consultation for a colonoscopy
- Patient who gave their consent for the study (signed consent form)
- Patient affiliated to a health insurance plan
Exclusion
- History of other cancers (except for cervical cancer or basal cell carcinoma treated for curative purposes)
- Patient under chemotherapy
- Patients with a known familial mutation (APC, MSI, MYH)
- Patients protected by law
Key Trial Info
Start Date :
January 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 7 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04394572
Start Date
January 7 2021
End Date
October 7 2022
Last Update
October 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092